U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07113756) titled 'New Topical Treatment in Plaque Psoriasis' on July 23.
Brief Summary: Psoriasis is a chronic, recurring, immune-mediated papulosquamous condition The etiology of psoriasis is complex and not fully understood Though many treatment options are available for plaque psoriasis, each has its limitations and side effects. Therefore, the need for an effective topical agent that delivers the drug efficiently into the target site with minimal systemic side effects remains an aim in itself.Metformin is a derivative of biguanide that is the most widely used as an oral antihyperglycemic agent for the control of diabetes mellitus. In addition to ...